Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam S Chang

Showing results (451-460 of 490) with videos related to

Pageof 49
Sort By:
The Journal of Urology|July 21, 2010
Smaller prostate size predicts high grade prostate cancer at final pathologyMark R Newton, Sharon Phillips, Sam S Chang, et al.
The Journal of Urology|September 25, 2012
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experienceSamuel D Kaffenberger, Kirk A Keegan, Neil K Bansal, et al.
American Journal of Human Genetics|March 4, 2014
An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibilityJoan P Breyer, Daniel C Dorset, Travis A Clark, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Commentary on Novitas LCDYair Lotan, Daniel A Barocas, Sam S Chang, et al.
Journal of Oncology Practice|August 11, 2017
Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline SummarySam S Chang, Bernard H Bochner, Roger Chou, et al.
The Journal of Urology|May 1, 2017
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO GuidelineSam S Chang, Bernard H Bochner, Roger Chou, et al.
European Urology Oncology|March 24, 2020
Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysisAshish M Kamat, Seth P Lerner, Michael O'Donnell, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not MatterAshish M Kamat, Niyati Lobo, Seth P Lerner, et al.
The Journal of Urology|April 25, 2023
Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO GuidelineJonathan A Coleman, Peter E Clark, Brooke R Bixler, et al.
BMC Cancer|November 19, 2023
Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancerJohn L Gore, Erika M Wolff, Bryan A Comstock, et al.
Pageof 49

Showing results (451-460 of 490) with videos related to

Sort By:
Pageof 49
The Journal of Urology|July 21, 2010
Smaller prostate size predicts high grade prostate cancer at final pathologyMark R Newton, Sharon Phillips, Sam S Chang, et al.
The Journal of Urology|September 25, 2012
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experienceSamuel D Kaffenberger, Kirk A Keegan, Neil K Bansal, et al.
American Journal of Human Genetics|March 4, 2014
An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibilityJoan P Breyer, Daniel C Dorset, Travis A Clark, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Commentary on Novitas LCDYair Lotan, Daniel A Barocas, Sam S Chang, et al.
Journal of Oncology Practice|August 11, 2017
Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline SummarySam S Chang, Bernard H Bochner, Roger Chou, et al.
The Journal of Urology|May 1, 2017
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO GuidelineSam S Chang, Bernard H Bochner, Roger Chou, et al.
European Urology Oncology|March 24, 2020
Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysisAshish M Kamat, Seth P Lerner, Michael O'Donnell, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Reduced Dose Intravesical Bacillus Calmette-Guérin: Why It Might Not MatterAshish M Kamat, Niyati Lobo, Seth P Lerner, et al.
The Journal of Urology|April 25, 2023
Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO GuidelineJonathan A Coleman, Peter E Clark, Brooke R Bixler, et al.
BMC Cancer|November 19, 2023
Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancerJohn L Gore, Erika M Wolff, Bryan A Comstock, et al.
Pageof 49